 |
|
New discovery may improve treatment of one of the world's leading causes of blindness
October 01, 2007GALVESTON, Texas - An inflammatory eye condition that is one of the world's leading causes of blindness could be treated much more effectively and easily thanks to a new discovery here.
In experiments with laboratory rats, scientists at the University of Texas Medical Branch at Galveston have developed a potential new therapy for uveitis - the inflammation of the uvea, a layer of tissue that lies just below the outer surface of the eyeball and includes the iris.
The condition, which can be caused by both autoimmune and infectious diseases, is estimated to cause from 5 to 15 percent of all cases of total blindness in the United States. Although exact figures are unavailable, the researchers say uveitis causes an even higher proportion of blindness in developing countries, because of the greater incidence there of infectious diseases and more limited availability of health care.
"The only thing a clinician can do now for uveitis is to treat the patient with steroids to reduce inflammation," said UTMB biochemistry and molecular biology assistant professor Kota Ramana, senior author of a paper on the discovery published in the October issue of Investigative Ophthalmology & Visual Science (now available online at http://www.iovs.org). "But steroids have serious side effects, and you can't use them for a long period of time."
That's not much of a problem when uveitis is produced by an infection that can be killed off in a few days with antibiotics, UTMB biochemistry and molecular biology professor and paper co-author Satish Srivastava explained. But if the source of the uveitis is an autoimmune disease like arthritis or lupus, in which the immune system mistakenly generates chronic inflammation in response to substances naturally present in the body, the lack of an alternative to steroids creates great difficulties for patients.
Ramana and the paper's other authors, Srivastava and postdoctoral fellow Umesh Yadav, took a different route to reduce inflammation, building on work Srivastava's group has already successfully applied to fighting colon cancer and sepsis in animal experiments. Working with rats that had been injected with a uveitis-generating bacterial toxin, they demonstrated that the eye-damaging inflammation could be stopped by treatment with a compound that blocks the action of aldose reductase, an enzyme essential to the production of inflammatory signaling molecules.
"We measured inflammatory markers in the untreated rats' eyes - during inflammation there are a lot of inflammatory signaling proteins and inflammatory cells secreted in the aqueous humor, the clear liquid inside the eyes," Ramana said. "The concentrations of those proteins and cells are much lower when we used the aldose reductase inhibitor. When we also studied different sections of the eyes of rats treated with aldose reductase inhibitor, for example the retinal region, we saw the same reduction in the signaling molecules that cause damaging inflammation."
The specific aldose reductase inhibitor used in the experiments was zopolrestat, which is currently in phase 3 clinical trials as a treatment for diabetic complications. But Srivastava said the same effect would likely be produced by other aldose reductase inhibitors, including one now approved for use in Japan.
"We have not reached the clinical trial stage as yet, but we are not far away," Srivastava said. "If the trials work out, we'd like to go for topical administration in drops, which would mean that only the tissues of the eye would be affected by the drug."
University of Texas Medical Branch at Galveston
"The only thing a clinician can do now for uveitis is to treat the patient with steroids to reduce inflammation," said UTMB biochemistry and molecular biology assistant professor Kota Ramana, senior author of a paper on the discovery published in the October issue of Investigative Ophthalmology & Visual Science (now available online at http://www.iovs.org). "But steroids have serious side effects, and you can't use them for a long period of time."
That's not much of a problem when uveitis is produced by an infection that can be killed off in a few days with antibiotics, UTMB biochemistry and molecular biology professor and paper co-author Satish Srivastava explained. But if the source of the uveitis is an autoimmune disease like arthritis or lupus, in which the immune system mistakenly generates chronic inflammation in response to substances naturally present in the body, the lack of an alternative to steroids creates great difficulties for patients.
Ramana and the paper's other authors, Srivastava and postdoctoral fellow Umesh Yadav, took a different route to reduce inflammation, building on work Srivastava's group has already successfully applied to fighting colon cancer and sepsis in animal experiments. Working with rats that had been injected with a uveitis-generating bacterial toxin, they demonstrated that the eye-damaging inflammation could be stopped by treatment with a compound that blocks the action of aldose reductase, an enzyme essential to the production of inflammatory signaling molecules.
"We measured inflammatory markers in the untreated rats' eyes - during inflammation there are a lot of inflammatory signaling proteins and inflammatory cells secreted in the aqueous humor, the clear liquid inside the eyes," Ramana said. "The concentrations of those proteins and cells are much lower when we used the aldose reductase inhibitor. When we also studied different sections of the eyes of rats treated with aldose reductase inhibitor, for example the retinal region, we saw the same reduction in the signaling molecules that cause damaging inflammation."
The specific aldose reductase inhibitor used in the experiments was zopolrestat, which is currently in phase 3 clinical trials as a treatment for diabetic complications. But Srivastava said the same effect would likely be produced by other aldose reductase inhibitors, including one now approved for use in Japan.
"We have not reached the clinical trial stage as yet, but we are not far away," Srivastava said. "If the trials work out, we'd like to go for topical administration in drops, which would mean that only the tissues of the eye would be affected by the drug."
University of Texas Medical Branch at Galveston
Blindness Current Events and Blindness News RSSConference report highlights new research into drug delivery to treat eye disease
Researchers are investigating microneedles, nanoparticles and polymer carriers as potential new techniques to combat the leading cause of visual impairment and blindness in the United States, according to a report from the Third Annual ARVO/Pfizer Ophthalmics Research Institute Conference.
Eye conditions linked with obstructive sleep apnea
If a good night's sleep helps the brain and body perform better, it's a good guess that sleep problems can cause more than just fatigue. Numerous studies have shown a connection between sleep disorders and medical conditions such as cardiovascular disease, cerebrovascular disease, and metabolic disorders, including the risk of obesity and diabetes mellitus. In the November issue of Mayo Clinic Proceedings, Mayo Clinic researchers outline several interesting associations between sleep disorders and eye disease.
Researchers find aggressive phototherapy can improve neurodevelopmental outcomes in some preemies
Researchers at The University of Texas Medical School at Houston say the use of aggressive phototherapy reduces the odds that tiny premature infants will develop neurodevelopmental impairment such as cerebral palsy, blindness, deafness or physical or mental challenges.
Contact lenses are home to pathogenic amoebae
Contact lenses increase the risk of infection with pathogenic protozoa that can cause blindness.
Man's best friend recruited in the hunt for disease genes
For centuries man has had a uniquely close relationship with dogs - as a working animal, for security and, perhaps most importantly, for companionship. Now, dogs are taking on a new role - they are helping in the hunt for genetic mutations that lead to diseases in humans.
Vision loss more common in people with diabetes
Visual impairment appears to be more common in people with diabetes than in those without the disease, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Keeping herpes infection in check: Pitt researchers describe immune system strategies
Herpes simplex virus type I can cause bouts of cold sores, blindness and potentially lethal encephalitis when it reawakens from a quiescent state in the nerve cells it infects.
Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye
An atomic-resolution view of an enzyme found only in the eye has given researchers at the University of Washington (UW) clues about how this enzyme, essential to vision, is activated.
Receptor could halt blinding diseases, stop tumor growth, preserve neurons after trauma
An international team of researchers has discovered what promises to be the on-off switch behind several major diseases.
Researchers create first model for retina receptors
A team of scientists at the University of Oklahoma Health Sciences Center has created the first genetic research model for a microscopic part of the eye that when missing causes blindness. The research appears in a recent issue of the Journal of Biological Chemistry.
More Blindness Current Events and Blindness News Articles
 | Blindness (Movie Tie-In) by Jose Saramago NOW A MAJOR MOTION PICTURE A city is hit by an epidemic of "white blindness" that spares no one. Authorities confine the blind to an empty mental hospital, but there the criminal element holds everyone captive, stealing food rations and assaulting women. There is one eyewitness to this nightmare who guides seven strangers—among them a boy with no mother, a girl with dark glasses, a dog of... |
 | Willful Blindness: Memoir of the Jihad by Andrew C. McCarthy Andrew C. McCarthy takes readers back to the real beginning of the war on terror--not the atrocities of September 11, but the first bombing of the World Trade Center in February 1993 when radical Islamists effectively declared war on the United States. From his perch as a government prosecutor of the blind sheik and other jihadists responsible for the bombing, Andrew McCarthy takes readers inside... |
 | Blindness by Saramago Jose A city is hit by an epidemic of "white blindness" which spares no one. Authorities confine the blind to an empty mental hospital, but there the criminal element holds everyone captive, stealing food rations and raping women. There is one eyewitness to this nightmare who guides seven strangers-among them a boy with no mother, a girl with dark glasses, a dog of tears-through the barren streets, and... |
 | Overcoming Spiritual Blindness by James P. Gills |
 | God, Money, and Politics: English Attitudes to Blindness and Touch, from the Enlightenment to Integration (PB) by Simon Hayhoe Our book examines the role of three factors, God, Money, and Politics, in the epistemological theory of blindness, (the theory of the construction of knowledge on blindness and touch by social and cultural change). This book also illustrates this development has, in the main, been motivated by an attempt to assert or gain power and why the study of blindness in conventional academic subjects such... |
 | Blindness and Children: An Individual Differences Approach (Cambridge Studies in Social & Emotional Development) by David H. Warren In this book, Dr. Warren summarizes and interprets the research literature on infants and children with visual impairments. He concludes that many aspects of delayed development are not the result of visual impairment itself, but rather of environmental variables that tend to accompany visual impairment. Thus, many of the typical developmental prdelays may be ameliorated or avoided by the... |
 | Do You Remember the Color Blue?: The Questions Children Ask About Blindness by Sally Hobart Alexander Children are often curious about blindness, but are told that it is impolite to pose their questions to a blind person. Not so, says Sally Hobart Alexander, who lost her sight at the age of twenty-six. In this informative book, illustrated with photos of Sally and her family, the author answers thirteen thought-provoking questions that children have asked her, for example, "If your eyes don't... |
 | Blindness and Insight: Essays in the Rhetoric of Contemporary Criticism (Theory & History of Literature) by Paul De Man |
 | Willful Blindness by Andrew C. McCarthy Long before the devastation of September 11, 2001, the war on terror raged. The problem was that only one side, radical Islam, was fighting it as a war. For the United States, the frontline was the courtroom. So while a diffident American government prosecuted a relative handful of “defendants,” committed militants waged a campaign of jihad—holy war—boldly targeting America’s greatest... |
 | Blindness (British Literature) by Henry Green Blinded in an accident on his way home from boarding school, John Haye must reevaluate his life and the possibilities for his future. His stepmother--worried that, blind and dependent, he'll spend the rest of his life with her--wants to marry him off to anyone who will take him, provided she's of the "right" social class. Contrary to her hopes, John falls in love with the daughter of the town... |
| © 2008 BrightSurf.com |